Acurable is a fast growing MedTech company headquartered in London. We produce the first wearable medical device able to accurately diagnose and manage respiratory conditions at home. Our award-winning patented technology is a major engineering innovation and the product of over 10 years research at Imperial College London.
- Accurate : 5x more accurate readings than current solutions, enabling automated diagnosis and drastically reducing misdiagnosis.
- Easy to use : non-invasive and no training required, enabling home use without the assistance of a specialist or a visit to the hospital, which significantly lowers overall costs.
We aim to understand human biosignals so well that nobody dies of a treatable condition ever again. To achieve our objectives, we are building a team of exceptional people who are inspired by our vision, share our values, and who have the attitude and skills required to help Acurable succeed.
- Accurate : 5x more accurate readings than current solutions, enabling automated diagnosis and drastically reducing misdiagnosis.
- Easy to use : non-invasive and no training required, enabling home use without the assistance of a specialist or a visit to the hospital, which significantly lowers overall costs.
We aim to understand human biosignals so well that nobody dies of a treatable condition ever again. To achieve our objectives, we are building a team of exceptional people who are inspired by our vision, share our values, and who have the attitude and skills required to help Acurable succeed.
Location: United Kingdom, England, London
Employees: 11-50
Total raised: $10.75M
Founded date: 2016
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.10.2022 | Series A | $10.75M | Alma Mundi... |
Mentions in press and media 6
| Date | Title | Description |
| 24.05.2023 | Meet the tiny, wireless sleep apnea diagnostic wearable headed for the US | UK medtech startup Acurable has gained FDA clearance for a novel wireless diagnostic device for remote detection of obstructive sleep apnea (OSA). A formal launch into the US market is slated to follow this summer. Its wearable is already b... |
| 10.10.2022 | Acurable closes a €11M series A round lead by Kibo and the participantion of Mundi Ventures, Kindred Capital and Comprador Holdings | 03/10/2022 Nota de prensa ACURABLE RAISES €11M IN SERIES A FUNDING ROUND Acurable, an award-winning wearable medical devices company, today announced an €11m investment as a result of its Series A funding round. These funds will be used ... |
| 03.10.2022 | Acurable raises €11M to expand at home sleep apnea testing device internationally | Photo: Courtesy of Acurable Photo: Courtesy of Acurable |
| 03.10.2022 | Acurable Raises €11M in Series A Funding Round | Acurable, a London, UK- and Seville, Spain-based medical devices company, raised €11M in Series A funding. The round was led by Kibo Ventures, with participation from Mundi Ventures, Kindred Capital, and Comprador Holdings. The company inte... |
| 12.10.2021 | Introducing: the 31 companies joining Upscale in 2021 | We are excited to announce the seventh cohort of companies selected for the Upscale programme, which supports mid-stage, fast-scaling tech companies in the UK. In line with increasing attention on healthtech and edtech in the last two year... |
| - | Acurable | “We create accurate and user friendly wearable medical devices intended to be used by patients at home” |